The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

April 2, 2014 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

There are many medications available to treat depression and anxiety, including tricyclic antidepressants, selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors, among others. Adverse effects, including anti­cholinergic effects, weight gain, increased appetite, sexual dysfunction and cardiovascular effects are concerns. It is also important to taper down dosages gradually and to educate patients that full therapeutic effects of many antidepressants may take up to six weeks, Dr. Arnold said. Patients should be maintained on antidepressants for one year after remission of symptoms, she added.

You Might Also Like
  • Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
  • 2013 ACR/ARHP Annual Meeting: Research Provides Insight into Preclinical Rheumatic Disease
  • Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
Explore This Issue
April 2014
Also By This Author
  • The ACR Has Introduced a New Reproductive Health Guideline Draft

Nonpharmacologic interventions may also help patients who experience pain and depression. Approaches include mindful meditation and emotion-regulation therapy, Dr. Arnold said. “Medications will alleviate symptoms, but will not help people deal with their emotional problems.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Bipolar disorder (BPD) is another common syndrome, and when it is comorbid with fibromyalgia, there might be increased suicide risk, Dr. Arnold said. Screening tests help identify BPD. “Anytime someone [says] an antidepressant made their mood worse, that is a red flag for bipolar disorder,” she said.

In chronic pain patients, predictors of suicide include poor sleep quality, use of illicit drugs, use of antidepressants, and being unemployed or on disability, Dr. Arnold said. Suicide-screening tests are useful in identifying high risk. “Patients will tell you whether they have suicidal [tendencies] or not.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Severe mood disorders are common in patients with rheumatic disease, and referral to psychiatric professionals may be necessary, Dr. Arnold concluded. Routine screening will help identify patients who may have comorbid psychiatric disorders, leading to faster treatment to alleviate symptoms and manage the patient’s disease more effectively.


Susan Bernstein is a writer based in Atlanta.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: ACR/ARHP Annual Meeting, ARHP, Association of Rheumatology Health Professionals, Depression, diagnostic tools, drug, Fibromyalgia, Pain, patient care, psychological disorder, Rheumatic Disease, Rheumatoid arthritis, rheumatologistIssue: April 2014

You Might Also Like:
  • Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
  • 2013 ACR/ARHP Annual Meeting: Research Provides Insight into Preclinical Rheumatic Disease
  • Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
  • 2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.